Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the active ingredient in ...

Novo Nordisk agrees to IRA price caps for Ozempic, Wegovy under Medicare in 2027. Get key sales, profit impacts, and market outlook.

Novo Nordisk said on Wednesday it has accepted the U.S. Inflation Reduction Act (IRA)'s maximum fair price for its diabetes ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar ...

President Trump denies that Americans are struggling with grocery prices and inflation. It’s the same mistake that haunted ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...